These 10 “Crisis-Proof” Funds Yield Up to 10% (with 17% upside)

Our Archive

Search completed

After watching the S&P 500 crash, then levitate, over the past seven months, I’ve come to one conclusion: high-yield closed-end funds (CEFs) are disrespected now—and that makes them a great contrarian buy.

Sure, some CEFs are cheap for a reason (I’m looking at you, energy funds). But there are plenty of undervalued winners, too. And plenty of CEFs have crushed the market this year, including 10 that have returned more than 8%. This top-10 list, which I’ll show you below, includes CEFs that have doubled, tripled—and even quadrupled the S&P 500’s 4% return.

What’s more, these funds all have one thing in common that sets them up for even bigger gains: strong management, proving once again that who manages your money is just as important as what you invest in—especially if you’re looking to boost your portfolio’s income stream with the 7% (or higher) dividends the typical CEF throws off.… Read more

Read More

Today I want to show you a beaten-down sector that has a long history of crushing the market—and 4 funds that should be on your radar now.

These 4 funds are a great place to pocket dividends up to 10.9% (or $10,900 a year on a $100k investment) while you wait for the market to realize that it’s discounting their industry far too much.

I’m talking about 4 standout fund buys from the biotech sector.

Biotech has fallen over 10% from its 2018 high and is now down a bit more than the broader market. Just look at the iShares Nasdaq Biotechnology ETF (IBB) vs.…
Read more

Read More

There are 20 elite closed-end funds (CEFs) that have proven their toughness in the last 10 years (including through the Great Recession, the most brutal test of all) and have still handed investors market-beating returns.

And below we’re going to look at all 20 of them.

So if you’re looking for a proven dividend payer that will hold its own through today’s troubles—trade wars and rising interest rates, to name just two—these 20 funds are a great place to start.

The Toughest of the Tough

Some of these cash machines throw off dividends of 6.8% or more (and one I’ll tell you about in a moment pays a sky-high 12.4%!).…
Read more

Read More

I had an odd experience a couple weeks ago.

I met up with some money managers and financial advisors. They were discussing the same problem: how tough it is to beat the market.

Since I focus on closed-end funds, and since I know of many CEFs that have beaten the market thanks to smart managers (I showed you 16 whose average return has crushed the S&P 500 back in November), I found this discussion puzzling. I asked them what they thought about the CEFs that have beaten the market.

The responses were pretty much the same. “It won’t continue … they were lucky … they just beat the market for a short period … index funds will ultimately outperform.”

A Cult in the Making

The trend toward passive index investing is turning into a cult.…
Read more

Read More

If you’ve held Apple (AAPL) for a long time, you’re probably feeling pretty smug. And you should—the stock is way up over just about any time period and has nearly doubled in the last five years:

Apple’s Sparkling Performance

Clearly, Apple is an amazing stock. But what if I told you we can top that 96.3% gain in the next five years?

All we have to do is go someplace most investors aren’t. I’m talking about high-yielding—and almost totally ignored—closed-end funds.

The three I want to show you today are the PIMCO Dynamic Income Fund (PDI), the Tekla Life Sciences Investors Fund (HQL) and the Western Asset Mortgage Defined Opportunity Fund (DMO).
Read more

Read More

Categories